260 related articles for article (PubMed ID: 26923810)
1. Nabilone for the Management of Pain.
Tsang CC; Giudice MG
Pharmacotherapy; 2016 Mar; 36(3):273-86. PubMed ID: 26923810
[TBL] [Abstract][Full Text] [Related]
2. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
Davis MP
Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
[TBL] [Abstract][Full Text] [Related]
3. The abuse potential of the synthetic cannabinoid nabilone.
Ware MA; St Arnaud-Trempe E
Addiction; 2010 Mar; 105(3):494-503. PubMed ID: 20402993
[TBL] [Abstract][Full Text] [Related]
4. Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial.
Wissel J; Haydn T; Müller J; Brenneis C; Berger T; Poewe W; Schelosky LD
J Neurol; 2006 Oct; 253(10):1337-41. PubMed ID: 16988792
[TBL] [Abstract][Full Text] [Related]
5. Medical marijuana for cancer.
Kramer JL
CA Cancer J Clin; 2015 Mar; 65(2):109-22. PubMed ID: 25503438
[TBL] [Abstract][Full Text] [Related]
6. Analgesic and antihyperalgesic effects of nabilone on experimental heat pain.
Redmond WJ; Goffaux P; Potvin S; Marchand S
Curr Med Res Opin; 2008 Apr; 24(4):1017-24. PubMed ID: 18302810
[TBL] [Abstract][Full Text] [Related]
7. Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial.
Turcotte D; Doupe M; Torabi M; Gomori A; Ethans K; Esfahani F; Galloway K; Namaka M
Pain Med; 2015 Jan; 16(1):149-59. PubMed ID: 25288189
[TBL] [Abstract][Full Text] [Related]
8. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Pertwee RG
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3353-63. PubMed ID: 23108552
[TBL] [Abstract][Full Text] [Related]
9. Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
Pertwee RG
Br J Pharmacol; 2009 Feb; 156(3):397-411. PubMed ID: 19226257
[TBL] [Abstract][Full Text] [Related]
10. An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.
Toth C; Mawani S; Brady S; Chan C; Liu C; Mehina E; Garven A; Bestard J; Korngut L
Pain; 2012 Oct; 153(10):2073-2082. PubMed ID: 22921260
[TBL] [Abstract][Full Text] [Related]
11. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
Ahmedzai S; Carlyle DL; Calder IT; Moran F
Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
[TBL] [Abstract][Full Text] [Related]
12. Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
Berlach DM; Shir Y; Ware MA
Pain Med; 2006; 7(1):25-9. PubMed ID: 16533193
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of cannabinoid neuromodulators in symptom management.
Davis M; Maida V; Daeninck P; Pergolizzi J
Support Care Cancer; 2007 Jan; 15(1):63-71. PubMed ID: 17139494
[TBL] [Abstract][Full Text] [Related]
14. Nabilone. A preliminary review of its pharmacological properties and therapeutic use.
Ward A; Holmes B
Drugs; 1985 Aug; 30(2):127-44. PubMed ID: 2863127
[TBL] [Abstract][Full Text] [Related]
15. [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].
Pinsger M; Schimetta W; Volc D; Hiermann E; Riederer F; Pölz W
Wien Klin Wochenschr; 2006 Jun; 118(11-12):327-35. PubMed ID: 16855921
[TBL] [Abstract][Full Text] [Related]
16. Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation.
Cameron C; Watson D; Robinson J
J Clin Psychopharmacol; 2014 Oct; 34(5):559-64. PubMed ID: 24987795
[TBL] [Abstract][Full Text] [Related]
17. Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents.
Sun N; Cunha N; Amar S; Brown S
Can J Pain; 2022; 6(1):225-231. PubMed ID: 36458026
[TBL] [Abstract][Full Text] [Related]
18. The pharmacologic and clinical effects of medical cannabis.
Borgelt LM; Franson KL; Nussbaum AM; Wang GS
Pharmacotherapy; 2013 Feb; 33(2):195-209. PubMed ID: 23386598
[TBL] [Abstract][Full Text] [Related]
19. Effects of nabilone, a synthetic cannabinoid, on postoperative pain.
Beaulieu P
Can J Anaesth; 2006 Aug; 53(8):769-75. PubMed ID: 16873343
[TBL] [Abstract][Full Text] [Related]
20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
